Main Conference Program



Lectures eligible for Continuing Education credits (CEs) are marked with an asterisk (*)


9:15-9:35 AM

Conference Welcome

Valerie Mojeiko, MAPS Deputy Director
Brad Burge, MAPS Director of Communications

Grand Ballroom, Oakland Marriott City Center

Valerie Mojeiko has worked with MAPS since 2001. She earned her B.A. in Interdisciplinary Studies from the California Institute of Integral Studies, prior to which she attended New College of Florida. She has received two years of specialized training and mentorship in results-driven non-profit management from The Management Center of Washington, DC, and has completed related courses with Interaction Associates of San Francisco and the Conflict Resolution Center of Santa Cruz. She has also completed coursework in clinical trials administration for pharmaceutical drug development. In her work leading MAPS’ psychedelic harm–reduction project, Valerie has prepared over 200 volunteers to provide peer–based psychedelic emergency services from Burning Man to Tel Aviv.

Brad Burge earned his B.A. in Communication and Psychology from Stanford University in 2005 and his M.A. in Communication from the University of California, San Diego in 2009. His graduate work focused on the political, scientific, and cultural changes required to make illicit drugs into legitimate medicines. In 2009, he presented his work on the history of the distinction between the recreational and medical use of drugs at the Critical Legal Studies conference at the University of Leicester in the UK. He has also interned for the Drug Policy Alliance and has a longstanding interest in drug policy reform and activism.

9:35-10:00 AM

The Founding and History of the Multidisciplinary Association for Psychedelic Studies (MAPS)

Rick Doblin, Ph.D., MAPS Founder and Executive Director
Grand Ballroom, Oakland Marriott City Center
Includes 15 minutes for Q&A

Rick Doblin, Ph.D., founded MAPS in 1986. His dissertation (Public Policy, Harvard’s Kennedy School of Government) was on “The Regulation of the Medical Use of Psychedelics and Marijuana,” and his master’s thesis (Harvard) focused on the attitudes and experiences of oncologists concerning the medical use of marijuana. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise “healthy” people, and to also become a legally licensed psychedelic therapist. He resides in Boston with his wife and three children.

10:00-10:10 AM

Ashawna: A Passionate and Clear Vision

Kim Hailey
Grand Ballroom, Oakland Marriott City Center

Last month, MAPS board member Ashawna Hailey died peacefully at her San Jose home. She is survived by her children, Neal and Nora, and by her twin brother Kim. Shawn and Kim worked together for thirty years. Shawn designed AMD’s first microprocessor, starting a heated rivalry with Intel. Later they founded Meta-Software Corporation. Their Hspice circuit simulator is used to design most of the integrated circuits in use today. They took the company public in 1995 and it is now part of Synopsys, the world’s largest electronic design automation company. As a philanthropist, Ashawna sought to reform government policies on psychedelic drugs and marijuana. She donated generously to a number of important organizations, including the American Civil Liberties Union, the Marijuana Policy Project, the Drug Policy Alliance, and MAPS, where she served on the Board of Directors for four and half years. At MAPS, Ashawna championed the study of MDMA-assisted psychotherapy and worked to develop MDMA into a prescription medicine for PTSD. Her latest cause was to fund MAPS’ Asperger’s pilot protocol.


10:30 AM-12:00 PM

PANEL: The Political Implications of Scientific Research with Psychedelics and Marijuana

Gary Johnson (former Governor of New Mexico), Aaron Houston (SSDP), Rob Kampia (MPP), Jay Rorty, J.D. (ACLU), Paul Armentano (NORML), and Steph Sherer (ASA)
Moderated by Richard Miller, Ph.D.
Grand Ballroom, Oakland Marriott City Center
Includes 30 minutes for Q&A

Governor Gary Johnson, who has been referred to as the “most fiscally conservative Governor” in the country, was the Republican Governor of New Mexico from 1994-2003. Term-limited, Johnson retired from public office in 2003. An avid skier, adventurer, and bicyclist, he has currently reached four of the highest peaks on all seven continents, including Mt. Everest. In 2009, after becoming increasingly concerned with the country’s out-of-control national debt and precarious financial situation, the Governor formed the OUR America Initiative, a 501(c)(4) non-profit that promotes fiscal responsibility, civil liberties, and rational public policy. He traveled to more than 30 states and spoke to over 150 conservative and libertarian groups during his time as Honorary Chairman.

As executive director of Students for Sensible Drug Policy, Aaron Houston oversees the work of a national staff that coordinates students on more than 200 campuses around the world. Named a “Rising Star of Politics” by Campaigns & Elections’ Politics Magazine in 2008, Aaron is a nationally recognized expert on drug policy and marijuana law having played a key role in pushing the Department of Justice to formally issue written guidelines on medical marijuana in October 2009. Aaron has appeared on NBC’s Today Show, The Colbert Report, FOX News, CNN, and NPR, and his efforts on Capitol Hill were chronicled in a 2007 Showtime original documentary, In Pot We Trust. A Bloomberg News review of the film noted that, “Anyone wondering how lobbyists operate will benefit from watching Houston. [He] is…clearly comfortable with political combat.”

Rob Kampia co-founded the Marijuana Policy Project (MPP) in January 1995 and has been its executive director ever since. Rob co-authored most of the medical marijuana laws currently on the books in 16 states and the District of Columbia, with MPP taking a leading role in passing the laws in Hawaii (2000), Montana (2004), Vermont (2004), Rhode Island (2006), Michigan (2008), Maine (2009), Arizona (2010), and Delaware (2011) Rob also oversaw the campaign to decriminalize the possession of marijuana in Massachusetts, where voters passed MPP’s ballot initiative in 2008. This is the only state to decriminalize marijuana via a vote of the people. Rob has testified before a U.S. House subcommittee twice (2001 and 2004), and has also testified before legislative committees in California, Maine, Maryland, Massachusetts, Nevada, Ohio, Vermont, and Washington state. Rob has been quoted in almost every newspaper in the U.S., and has appeared on national TV dozens of times, including The Today Show (NBC), the Montel Williams Show (CBS), the NewsHour with Jim Leh
(PBS), Glenn Beck (Fox News Channel), Anderson Cooper 360 (CNN), Power Lunch (MSNBC), Geraldo Rivera Live (CNBC), Happy Hour (Fox Business Network), and the special Marijuana: A Chronic History (History Channel).

Jay Rorty, J.D. is the head of the Police Misconduct Unit of the San Francisco Public Defender. He is the former Director of the national ACLU’s Criminal Law Reform Project. In that capacity, he won significant victories in federal criminal cases by challenging the scientific validity of the United States Sentencing Guidelines for MDMA. The cases undermine the DEA’s position on the harms of MDMA and pave the way for a chance in federal penalties for MDMA. He is a former Federal Public Defender and has collaborated with MAPS in a number of projects and litigation.

Paul Armentano is the Deputy Director of NORML and the NORML Foundation. Mr. Armentano is an expert in the field of marijuana policy, health, and pharmacology, and has served as a consultant for Health Canada and the Canadian Public Health Association. He has spoken at numerous national conferences and legal seminars, testified before state legislatures and federal agencies, and assisted dozens of criminal defense attorneys in cases pertaining to the use of medicinal cannabis, drug testing, and drugged driving. He also serves of the faculty of Oaksterdam University in Oakland, where he lectures on the science surrounding the safety and efficacy of medical cannabis. He is the author of Emerging Clinical Applications for Cannabis, which reviews some 200 clinical and preclinical studies assessing the therapeutic properties of marijuana and its cannabinoids. Mr. Armentano is a frequent guest on national radio and television, having appeared on FoxNews, MSNBC, and CBS News. His writing and research has appeared in approximately 1,000 publications, including The New York Times, Washington Post, and The Christian Science Monitor, as well as in some two-dozen textbooks and anthologies. Mr. Armentano is a 2008 recipient of the ‘Project Censored Real News Award for Outstanding Investigative Journalism.’ In 2009, he co-authored the book Marijuana is Safer: So Why Are We Driving People to Drink?, which has appeared on’s best-sellers list and has been recently licensed and translated internationally.

As the founder of Americans for Safe Access, Executive Director Steph Sherer has become the foremost international leader and expert on medical cannabis patient advocacy. Her vision for keeping patients’ needs at the forefront of the medical marijuana debate has brought safe and legal access to millions of Americans. Steph is a medical cannabis patient with over 14 years of experience servicing and managing non-profit businesses and community organizations. Through her work at ASA, she has built a powerful organization by bringing together an exceptional staff team, prominent volunteer leaders, and thousands of patient activists nationwide. She has created the strategic framework for ASA, and in addition to harnessing the resources to implement her vision, she participates in the organization as a patient spokesperson, an organizer, a trainer, and a lobbyist for patients’ rights.

Richard Miller, Ph.D. is Founder & CEO of Wilbur Hot Springs Health Maintenance Organization, providing healing, prevention, and health maintenance. As the Founder of the internationally acclaimed Cokenders Alcohol and Drug Program, Dr. Miller integrated his techniques of humanistic psychology and psychophysical fitness training with social models of rehabilitation. Dr. Miller’s innovative approaches to healing have been the subject of national television news reports (including segments on the news programs of Tom Brokaw, Dan Rather, David Brinkley and Phil Donahue), print media (Time, Newsweek, and US News & World Report), two film documentaries, and the book Gestalting Addiction. In order to share information with the general public, he co-authored a weekly news column in the San Francisco Chronicle while co-hosting a weekly syndicated radio program. Dr. Miller has presented his work at national conferences of the American Psychological Association, the American Academy of Psychotherapists, and the White House Conference on Drugs. He has spent 50 years studying, teaching, researching, administering, and practicing psychology, health education, psychotherapy and executive consulting.


1:45-2:40 PM

Two Decades of Politics and Science in Medical Marijuana Research*

Donald Abrams, M.D.

Dr. Abrams will present the results of his groundbreaking research on marijuana as a treatment for pain and symptoms of HIV/AIDS, as well as from his seminal vaporizer studies. He will also explore the implications of that work for future research in the field.

Grand Ballroom, Oakland Marriott City Center
Includes 10 minutes for Q&A

Donald I. Abrams, M.D. is Chief of the Hematology-Oncology Division at San Francisco General Hospital and a Professor of Clinical Medicine at the University of California, San Francisco. He has an Integrative Oncology consultation practice at the UCSF Osher Center for Integrative Medicine. He received an Molecular Biology from Brown University in 1972 and graduated from the Stanford University School of Medicine in 1977. After completing an Internal Medicine residency at the Kaiser Foundation Hospital in San Francisco, he became a fellow in Hematology/Oncology at the Cancer Research Institute of the University of California, San Francisco in 1980. He was one the original clinician-investigators to recognize and define many early AIDS-related conditions. He has long been interested in clinical trials of complementary and alternative medicine interventions for HIV/AIDS and cancer, including evaluations of medicinal marijuana, as first inspired by Rick Doblin in 1992. In 1997 he received funding from the National Institute on Drug Abuse to conduct clinical trials of the short-term safety of cannabinoids in HIV infection. Subsequently he was granted funds by the University of California Center for Medicinal Cannabis Research to continue studies of the effectiveness of cannabis in a number of clinical conditions. He completed a placebo-controlled study of smoked cannabis in patients with painful HIV-related peripheral neuropathy as well as a study evaluating vaporization as a smokeless delivery system for medicinal use. His last NIDA-funded trial investigated the possible pharmacokinetic interactions between vaporized cannabis and opioid analgesics in patients with chronic pain. He co-authored the chapter on “Cannabinoids and Cancer” in the Oxford University Press Integrative Oncology text that he co-edited with Andrew Weil.

2:45-3:45 PM

PANEL: Marijuana Research

Dale Gieringer, Ph.D., Lyle Craker, Ph.D., Allen Hopper, J.D., and Sue Sisley, M.D.
Moderated by Donald Abrams, M.D.

A panel of experts lead an open dialogue about medical marijuana research, focusing primarily on the political struggles that MAPS has been engaged in since 1992 to develop the marijuana plant into an FDA-approved prescription medicine. Speakers will discuss MAPS’ efforts with Prof. Craker to obtain a DEA license to start our own medical marijuana production facility, currently in litigation against the DEA, our marijuana/PTSD protocol that FDA has accepted but NIDA has refused to sell us the marijuana, and about marijuana harm reduction and vaporization research conducted by MAPS a
nd CaNORML (also blocked by NIDA).

Grand Ballroom, Oakland Marriott City Center
Includes 15 minutes for Q&A

Dale Gieringer, Ph.D. has been State Director of California NORML (National Organization for the Reform of Marijuana Laws) since 1987. In this capacity he has spoken with thousands of medical marijuana users and is the author of the Marijuana Medical Handbook. He is Vice-Chairman of the national NORML Board of Directors. He is also Director of the California Drug Policy Forum (DPFCA) and treasurer of the Oakland Civil Liberties Alliance (OCLA). He has published research on the economic benefits of legalization, medical marijuana usage, the history of marijuana and drug prohibition, potency testing, marijuana and driving safety, and drug urinalysis. He sponsored path-breaking research and development on vaporizers as a smoke-free delivery system for cannabis. He has testified before the legislature, local governments, and courts on issues related to marijuana. He was one of the original co-authors of California’s medical marijuana initiative, Prop. 215, the proponent of Oakland’s Measure Z cannabis initiative in 2004, a sponsor of California’s pathbreaking legalization bill AB 390, and a consultant on numerous other cannabis reform campaigns.

Lyle Craker, Ph.D., Director of the Medicinal Plant Program at the University of Massachusetts-Amherst, has been working with MAPS for over 10 years to end the federal government’s monopoly on marijuana for research by applying for a license to start a MAPS-sponsored marijuana farm for research. He received his undergraduate degree from the University of Wisconsin and his doctorate from the University of Minnesota. He served two years as a Chemical Corp Officer at Fort Detrick, Maryland, then began work at the University of Massachusetts where his focus has centered on the production and chemistry of medicinal and aromatic plants. Dr. Craker was founding Editor for the scientific Journal of Herbs, Spices, and Medicinal Plants and is currently founding Editor of the Journal of Medicinally Active Plants. He organized the Herb, Spice, and Medicinal Plant Working Group in the American Society for Horticultural Science and served six years as Chairman of the Medicinal and Aromatic Plant Section in the International Society for Horticutural Science which awarded him a lifetime honorary membership for his service to the Society. His organization of a medicinal plant program at the University of Massachusetts consists of nine courses enrolling approximately 220 students each year.

Allen Hopper, J.D., is an attorney and the Criminal Justice and Drug Policy Director at the American Civil Liberties Union (ACLU) of Northern California, where he develops and implements strategies to reform California’s criminal justice system and drug policies. Specific areas of focus include down-sizing California jails and prisons, drug law enforcement, medical marijuana implementation issues, and broader marijuana law reform. Prior to moving to the California ACLU, Mr. Hopper was the Litigation Director for the National ACLU’s Drug Law Reform Project, where he coordinated the ACLU’s drug policy-related litigation and litigated cases across the nation as part of an overall strategy to combine impact litigation with policy and legislative advocacy, public education, media, and grassroots-and-tops organizing to transform public understanding of, and government response to, drug use and drug policies.

Sue Sisley, M.D. is the Clinical Investigator for MAPS’ planned study of marijuana for symptoms of PTSD in veterans of war. Dr. Sisley began her full-time TELEMEDICINE practice starting in 2009, where she employs a full array of telecommunications technology to continue delivering high-quality medical care to populations across rural/underserved areas of Arizona. She is an Institutional Member of the American Telemedicine Association and serves on the ATA’s Legislative and Policy Committee. She also serves as Clinical Faculty at St. Joseph’s Hospital and Medical Center at the MercyCare Adult Medicine Clinic for indigent patients. Dr. Sisley completed her medical degree at the University of Arizona College of Medicine and proceeded to complete her five-year Residency Training at Good Samaritan Regional Medical Center in the fields of Internal Medicine and Psychiatry. Dr. Sisley also founded and serves as CEO of a non-profit corporation entitled Ensuring Tomorrow Productions, an organization that delivers health education through music, theater, and dance. Dr. Sisley has received many recent honors including the President’s Point of Light Award and the Leo B. Hart Humanitarian Award for “outstanding contributions made for social reform” by the University of Arizona College of Medicine. Dr. Sisley was also given the Arizona Medical Association’s highest honor, the President’s Distinguished Service Award, and received Arizona’s most prestigious recognition for volunteerism, the Hon Kachina Award.


4:00-4:40 PM

Ibogaine Research in Opiate Addicts*

Thomas Kingsley Brown, Ph.D.
Moderated by Valerie Mojeiko
Grand Ballroom, Oakland Marriott City Center
Includes 10 minutes for Q&A

Thomas Kingsley Brown, Ph.D. is a researcher and educator at the University of California, San Diego. His professional background and training is in chemistry, neuroscience, and anthropology. He holds a B.S. in Chemistry from the University of Pittsburgh, an M.S. in Chemistry from the California Institute of Technology, and both an M.A. and Ph.D. in Anthropology from UCSD. At CalTech Tom achieved doctoral candidacy while working in a neurobiology lab studying the chemistry of learning and memory; however, his ethical qualms with animal research—in concert with some intense, mind-altering experiences—motivated him to leave the hard sciences behind in order to pursue studies of human consciousness. He worked briefly as a political activist in Los Angeles and as a lab technician at the University of Pennsylvania (Dept. of Neurology) before starting doctoral studies at UCSD, where he researched and wrote about altered states of consciousness, paranormal phenomena, and religious conversion. He has taught anthropology courses on religion, the environmental crisis, and mental illness and deviance. In November of 2009 he undertook a study of personal narratives and quality of life changes for people at ibogaine clinics in Baja Californa, Mexico, and in 2010 he began working on the MAPS-funded long-term outcomes study of ibogaine-assisted treatment for opiate dependence. He resides in San Diego with his partner and their two sons.

4:45-5:45 PM

LSD Research for End-of-Life Anxiety*

Peter Gasser, M.D.
Grand Ballroom, Oakland Marriott City Center
Includes 15 minutes for Q&A

Peter Gasser, M.D. was born in Switzerland in 1960 and works as a psychiatrist and psychotherapist in his own private practice. In 2007 he started a small, still running, MAPS-sponsored study of LSD-assisted psychotherapy for individuals suffering from anxiety as a result of advanced-stage illness. His interest for drug-assisted psychotherapy started in the late 1980s, when therapy with LSD and MDMA was legal in Switzerland for a five-year period. Dr. Gasser is member of the Swiss Medical Society for Psycholytic (Psychedelic) Therapy since 1992 and the society’s president since 1997. He is married and father of 3 children.

6:30-7:30 PM (optional)

Film Screening: The Jungle Prescription

6:30-7:30 PM
Oakland Marriott Cit
y Center
Room 208

The Jungle Prescription tells of ayahuasca, a visionary Amazonian brew of indigenous origin and its encounter with the West, as played out through the story of two doctors. The first, Dr. J. Mabit, runs a legendary detox centre deep in the Peruvian jungle, in partnership with indigenous healers. The second, Dr. Gabor Maté, is trying to establish a similar program in Canada of which MAPS is conducting an observational study. Through the intimate stories of these doctors and their patients, we see how an ancient medicine causes cathartic, life-changing insight, and we witness the commitment of people who have devoted their whole lives to applying this medicinal knowledge.

{ tickets available now }


1:00-1:40 PM

Ayahuasca Research for Addiction*

Philippe Lucas, M.A.
Grand Ballroom, Oakland Marriott City Center
Includes 15 minutes for Q&A

Philippe Lucas, M.A., is a Research Affiliate with the Center for Addictions Research of British Columbia (CARBC), a member of the CARBC Advisory Board, and the founder of the Vancouver Island Compassion Society ( His current research interests, projects, and publications include the use of cannabis, ibogaine, and ayahuasca in the treatment of addiction, and he is the Coordinator and Co-Investigator of a cutting-edge MAPS Canada-sponsored observational study of ayahuasca-assisted treatment for addiction and stress currently underway on Canada’s West Coast. A founding board member of MAPS Canada and the Canadian Drug Policy Coalition, in 2008 Philippe was elected as a Victoria City Councillor, where his focus has been on social justice issues such as harm reduction, homelessness, environmental sustainability, and food security.

1:45-3:00 PM

MDMA-Assisted Therapy for PTSD Research*

Michael Mithoefer, M.D.
Grand Ballroom, Oakland Marriott City Center
Includes 20 minutes for Q&A

Michael Mithoefer, M.D., is a psychiatrist practicing in Charleston, SC, where he divides his time between clinical research and outpatient clinical practice specializing in treating posttraumatic stress disorder (PTSD) with an emphasis on experiential methods of psychotherapy. He is a Grof-certified Holotropic Breathwork Facilitator and is trained in EMDR and Internal Family Systems Therapy. He and his wife, Annie Mithoefer, recently completed a MAPS-sponsored Phase II clinical trial testing MDMA-assisted psychotherapy for PTSD. A paper about their study was published in July 2010 in the Journal of Psychopharmacology. They are currently conducting a second trial with veterans who have PTSD resulting from service in the U.S. Armed Forces, as well as psychotherapy training programs for MAPS researchers. Dr. Mithoefer is the medical monitor for MAPS-sponsored clinical trials in Europe, the Middle East and Canada. Before going into psychiatry in 1995 he practiced emergency medicine for ten years, served as medical director of the Charleston County and Georgetown County Emergency Departments, and has held clinical faculty positions at the Medical University of South Carolina. He is currently board certified in Psychiatry, Emergency Medicine, and Internal Medicine.


3:15-4:45 PM

PANEL: MDMA-Assisted Therapy for PTSD Research: Phase 1 and 2 Pilot Studies*

Michael Mithoefer, M.D., Charles Grob, M.D., Berra Yazar-Klosinski, Ph.D., and Ingrid Pacey, M.D.
Grand Ballroom, Oakland Marriott City Center
Includes 30 minutes for Q&A

Michael Mithoefer, M.D. (see above)

Charles S. Grob, M.D. is Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center, and Professor of Psychiatry and Pediatrics at the UCLA School of Medicine. In the early 1990s he conducted the first government-approved psychobiological research study of MDMA, and was the principal investigator of an international research project in the Brazilian Amazon studying ayahuasca. He has also completed an investigation of the safety and efficacy of psilocybin treatment in advanced-cancer patients with anxiety and published his findings in the January 2011 issue of the Archives of General Psychiatry.

Berra Yazar-Klosinski, Ph.D., earned her doctorate in Molecular, Cell and Developmental Biology from the University of California, Santa Cruz in 2010, and utilizes her scientific training and experience in for-profit pharmaceutical research to help lead MAPS’ clinical team to develop, design, and implement clinical psychedelic research in the U.S and beyond. She earned her B.S. in Biological Science from Stanford University, with an emphasis on the neurobiology of drugs. Prior to entering graduate school, Berra worked as a Research Associate with Geron Corporation screening for drugs that activate telomerase, and with Millennium Pharmaceuticals on Phase 1 clinical trials to treat Acute Myeloid Leukemia. Berra joined MAPS in order to work with an organization where profit wouldn’t dictate the agenda of scientific research.

Ingrid Pacey, M.D., is the principal investigator for MAPS’ upcoming Canadian study of MDMA-assisted psychotherapy for PTSD. She has been a psychiatrist for 35 years and her work has focused on therapy for trauma survivors. She trained in Holotropic Breathwork from 1987-1990 with Stan and Christina Grof and facilitated Breathwork groups from 1990-2004. Ingrid worked a lot in these groups with trauma survivors and has written about this work in The Inner Door, the journal of the Association for Holotropic Breathwork International. She is looking forward to beginning working with trauma survivors using MDMA assisted psychotherapy.


5:00-5:35 PM

Constitutional Freedoms, the Uses of Psychedelics, and MAPS’ Mission

Ethan Nadelmann, J.D., Ph.D.
Grand Ballroom, Oakland Marriott City Center
Includes 15 minutes for Q&A

Ethan Nadelmann is the founder and executive director of the Drug Policy Alliance, the leading organization in the United States advocating for drug policies grounded in science, compassion, health, and human rights. Nadelmann was born in New York City, received his BA, JD, and PhD from Harvard, as well as a M.Sc. in International Relations from the London School of Economics, and then taught politics and public affairs at Princeton University from 1987 to 1994. He has authored two books on international criminal law enforcement—Cops Across Borders and (with Peter Andreas) Policing the Globe—as well as many dozens of articles on drug policy in publications such as Foreign Affairs, Foreign Policy, Science, International Organization, National Review, and The Nation. Described by Rolling Stone as “the point man” for drug policy reform efforts, Ethan Nadelmann is widely regarded as the outstanding proponent of drug policy reform both in the United States and abroad.

5:40-6:00 PM

Closing Sentiments and the Future of MAPS

Rick Doblin, Ph.D.
Grand Ballroom, Oakland Marriott City Center


*CEs for psychologists are provided by The Spiritual Competency Resource Center (SCRC) which is co-sponsoring this program and is approved by the American Psychological Association to sponsor continuing education for psychologists. SCRC maintains responsibility for the program and its content. SCRC is a California Board of Registered Nursing Provider (BRN) and a Board of Behavioral Sciences Provider (BBS). For questions about CE, visit the SCRC website or contact David Lukoff, PhD at or 707-763-3576.